In this report, we also performed CYP11A1 mRNA half-life and mRNA degradation studies, to determine the overall contribution of increased CYP11A1 stability to increased gene expression in PCOS theca cells. The gene discussed is CYP11A1; the disease is polycystic ovary syndrome.